Aileen Zhou

Aileen brings over a decade of experience in regulatory affairs working with innovative medical devices in domestic and global markets. Prior to joining NuraLogix, Aileen held several regulatory leadership positions, including Senior Manager, Regulatory Affairs at Centre for Commercialization of Regenerative Medicine (CCRM) and Project Manager, Regulatory Affairs at Synaptive Medical, a global medical device and technology company. In these roles, Aileen provided pivotal regulatory leadership throughout the product lifecycle and played a leading role in regulatory filings and product registrations in the U.S., Canada, EU, Australia, and other international markets. Prior to that, Aileen held several positions in scientific and regulatory affairs at Induce Biologics, an innovative tissue engineering company. During her tenure, Aileen single-handedly built up the entire regulatory asset and led several successful interactions with Health Canada and the U.S. FDA.

Aileen earned a PhD with a focus in biotechnology as an NSERC scholar and a Bachelor of Applied Science in biomedical engineering, both from the University of Toronto. She is an active member and contributing author of Regulatory Affairs Professional Society.